This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Life changes impact budgeting in many ways. This intro shows how to anticipate shifts, recalibrate goals, and keep your finances stable.
22,101 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Software is turning everyday machines into profit machines. This article spotlights two stocks that could soar as aut...
As the cost of nursing-home care climbs past six figures annually, medicare won’t touch long-term care costs, forcing...
A new DeFi bill in Congress could reshape who bears liability and how crypto markets are organized. This article brea...
A notable stake reduction in NMI Holdings highlights how large investors weigh growth, risk, and value. Here’s what i...
A fresh inflation outlook from the FED just arrived in May, and markets moved on the news. This article breaks down w...
Investors are watching Redwire as its stock keeps rising, driven by backlog gains and contract momentum. This guide b...
A renewed uptrend in Bloom Energy stock has caught investors’ attention. This analysis breaks down the why, how it co...
The latest Social Security Trustees report shows social security took $1.45 in revenue in 2025, but outlays exceeded ...
Global brain health costs total $5 trillion annually, with forecasts for $16 trillion by 2030. The crisis is reshapin...
A new analysis ties the united states’ trillion national debt to slower job growth for Gen Z and lower wages, project...
As higher interest rates bite into fixed retiree incomes, Suze Orman argues that paying only the minimum on credit ca...